The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Patterns of second-line treatment in patients with NSCLC and targetable mutations.

Shuchi  Pandey

No Relationships to Disclose

Muskan  Agarwal

No Relationships to Disclose

Nilansh  Kataria

No Relationships to Disclose

Chul  Kim

Consulting or Advisory Role - Bayer; Bicycle Therapeutics; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; Janssen; Onviv; Pinetree; Regeneron; Sanofi; Takeda

Research Funding - AstraZeneca; Black Diamond Therapeutics; Boehringer Ingelheim; Daiichi Sankyo; Genentech/Roche; Gilead Sciences; Janssen; Lyell Immunopharma; Macrogenics; Novartis; ORIC Pharmaceuticals; Regeneron